ID   VMM14
AC   CVCL_A735
DR   Wikidata; Q54993231
RX   PubMed=20856146;
RX   PubMed=21654344;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
RX   PubMed=20856146; DOI=10.1097/CMR.0b013e32833fafb4; PMCID=PMC3229868;
RA   Mikesh, Leann M.
RA   Kumar, Manish
RA   Erdag, Gulsun
RA   Hogan, Kevin T.
RA   Molhoek, Kerrington R.
RA   Mayo, Marty W.
RA   Slingluff, Craig L. Jr.
RT   "Evaluation of molecular markers of mesenchymal phenotype in
RT   melanoma.";
RL   Melanoma Res. 20:485-495(2010).
//
RX   PubMed=21654344; DOI=10.1097/CMR.0b013e328343a1d6; PMCID=PMC3131461;
RA   Molhoek, Kerrington R.
RA   Shada, Amber L.
RA   Smolkin, Mark
RA   Chowbina, Sudhir
RA   Papin, Jason
RA   Brautigan, David L.
RA   Slingluff, Craig L. Jr.
RT   "Comprehensive analysis of receptor tyrosine kinase activation in
RT   human melanomas reveals autocrine signaling through IGF-1R.";
RL   Melanoma Res. 21:274-284(2011).
//